The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Healthcare & Insurance

Interim Report Q2 2018: Continued double digit organic revenue growth drives strong EBITA margin increase. GN Audio upgrades organic growth guidance

GN Store Nord delivered 11% organic revenue growth in Q2 2018. Revenue growth was 7% including around (5)% impact from development in foreign exchange ratesEBITA margin increased 1.5 percentage points in Q2 2018 as a function of strong operational execution EPS increased 10% compared to Q2

Wednesday, August 22, 2018

Kane Biotech Announces Second Quarter 2018 Financial Results

WINNIPEG, Manitoba, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its Second Quarter 2018 Financial Results. Kane Biotech Inc. is a biotechnology company engaged in the research, development and

Tuesday, August 21, 2018

Neon Therapeutics Appoints Jolie M. Siegel as General Counsel

CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the appointment of Jolie M. Siegel as general counsel, a newly created position. Ms. Siegel will lead

Tuesday, August 21, 2018

Rubius Therapeutics to Announce Second Quarter 2018 Financial Results

CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, plans to report second quarter 2018 financial results on Friday, August 31, 2018. The company will

Tuesday, August 21, 2018

Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results

Total Fourth-Quarter Revenues of $200.9 MillionFourth-Quarter Diluted EPS of $0.18 and Adjusted EPS of $0.38, Up 31 Percent SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and

Tuesday, August 21, 2018

NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare

WALTHAM, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK Consumer Healthcare. A milestone payment of $3.8 Million was made by GSK. The collaboration with

Tuesday, August 21, 2018

Ageas and BlackRock: Transparency notification

In accordance with the rules on financial transparency*, Blackrock has notified Ageas on 16 August 2018 that, on 14 August 2018, its shareholding stands at 5.14%. * article 14, paragraph 1 of the law of 2 May 2007 on disclosure of major holdings us provisions Ageas is a listed

Tuesday, August 21, 2018

Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy

EAST SETAUKET, NY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that it has entered into a Clinical Trial Agreement and Exclusive License Agreement with Moffitt Cancer Center to conduct a Phase 1b/2 study of the safety and therapeutic benefit of

Tuesday, August 21, 2018

NewLink Genetics to Participate in the Baird Global Healthcare Conference

AMES, Iowa, Aug. 21, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company will present at the 2018 Baird Global Healthcare Conference on Wednesday, September 5, 2018, at 11:25AM ET.  A live webcast of the presentation will be available on the

Tuesday, August 21, 2018

Lexington Announces First Multicenter Clinical Study Site

Company embarks on pivotal clinical studyVANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce the Medical College of Wisconsin

Tuesday, August 21, 2018

Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO

Mandesh Dosanjh brings extensive consumer products experience with recent cannabis focus at Liquor Control Board of Ontario VICTORIA, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) and Village Farms International,

Tuesday, August 21, 2018

First Patient Enrolled in Delcath Amended Registration Trial in Metastatic Ocular Melanoma

NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the first patient has been enrolled under the amended protocol for its registration trial in

Tuesday, August 21, 2018

Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with

Pint Pharma to facilitate expansion of Phase 3 INSPIRE trial to Argentina, Chile, and Brazil in preparation for future studies of oral rigosertib NEWTOWN, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on

Tuesday, August 21, 2018

Progressive Care Inc. Reports 47% Increase in Prescriptions Filled During July 2018

MIAMI, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for July 2018. July brought a total of $1.887 million in net

Tuesday, August 21, 2018

GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy

SOUTH SAN FRANCISCO, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Heidi L. Wagner as senior vice president, government affairs and policy. Ms. Wagner joins GBT from Alexion Pharmaceuticals, where she was senior

Tuesday, August 21, 2018

Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin™) in combination with KEYTRUDA® (pembrolizumab)

ROCKVILLE, Md. , Aug. 21, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that it has entered into a clinical trial collaboration

Tuesday, August 21, 2018

BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

RALEIGH, N.C., Aug. 21, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading commercial specialty pharmaceutical company dedicated to patients living with chronic pain, today announced that Herm Cukier, Chief Executive Officer will present at the Rodman

Tuesday, August 21, 2018

CLS Holdings USA Names Matthew Janz as VP of Marketing and Director of Operations at Oasis Cannabis

Will Lead New Marketing Programs LAS VEGAS, Aug. 21, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiary, today

Tuesday, August 21, 2018

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences

PLYMOUTH MEETING, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that the Company will participate in the following upcoming investment conferences: Rodman and Renshaw 20th Annual Global Investment Conference, sponsored by H.C. Wainwright

Tuesday, August 21, 2018

Biotricity Expands Salesforce to Cover Key US Markets and Begins Advisory Board Expansion to Move Into Preemptive Heart Disease Diagnostics

The Company has Expanded its Sales Team to Cover Two Additional Geographic Centers in the USREDWOOD CITY, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, has expanded its sales team to cover two additional

Tuesday, August 21, 2018

loading

© 2018 Stock News Now